Anti-heparanase monoclonal antibody enhances heparanase enzymatic activity and facilitates wound healing

FASEB Journal

Volumn 21, Issue 14, 2007, Pages 3986-3993

  Gingis Velitski, Svetlana ^a   Ishai Michaeli, Rivka ^b   Vlodavsky, Israel ^a   Ilan, Neta ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cell invasion; Cell migration; Heparan sulfate; Stimulatory antibody

Indexed keywords

HEPARANASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HEPARANASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SURVIVAL; WOUND HEALING;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL LINE, TUMOR; ENZYME ACTIVATION; GLUCURONIDASE; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; UP-REGULATION; WOUND HEALING;

MAMMALIA;

EID: 36849054989     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8866com     Document Type: Article

References (42)

1. Pikas, D. S., Li, J.-p., Vlodavsky, I., and Lindahl, U. (1998) Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem. 273, 18770-18777
2. Vlodavsky, I., and Friedmann, Y. (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108, 341-347
3. Vlodavsky, I., Abboud-Jarrous, G., Elkin, M., Naggi, A., Casu, B., Sasisekharan, R., and Ilan, N. (2006) The impact of heparanase and heparin on cancer metastasis and angiogenesis. Pathophysiol. Haemost. Thromb. 35, 116-127
4. Edovitsky, E., Elkin, M., Zcharia, E., Peretz, T., and Vlodavsky, I. (2004) Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J. Natl. Cancer Inst. 96, 1219-1230
5. Edovitsky, E., Lerner, I., Zcharia, E., Peretz, T., Vlodavsky, I., and Elkin, M. (2005) Role of endothelial heparanase in delayedtype hypersensitivity. Blood 107, 3609-3616
6. Ilan, N., Elkin, M., and Vlodavsky, I. (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 38, 2018-2039
7. McKenzie, E. A. (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br. J. Pharmacol. 151, 1-14
8. Miao, H. Q., Liu, H., Navarro, E., Kussie, P., and Zhu, Z. (2006) Development of heparanase inhibitors for anti-cancer therapy. Curr. Med. Chem. 13, 2101-2111
9. Levidiotis, V., Kanellis, J., Ierino, F. L., and Power, D. A. (2001) Increased expression of heparanase in puromycin aminonucleoside nephrosis. Kidney Int. 60, 1287-1296
10. Waterman, M., Ben-Izhak, O., Eliakim, R., Groisman, G., Vlodavsky, I., and Ilan, N. (2006) Heparanase upregulation by colonic epithelium in inflammatory bowel disease. Mod. Pathol. 20, 8-14
11. Bar-Ner, M., Eldor, A., Wasserman, L., Matzner, Y., Cohen, I. R., Fuks, Z., and Vlodavsky, I. (1987) Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood 70, 551-557
12. Nakajima, M., Irimura, T., Di Ferrante, N., and Nicolson, G. L. (1984) Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J. Biol. Chem. 259, 2283-2290
13. Ferro, V., Hammond, E., and Fairweather, J. K. (2004) The development of inhibitors of heparanase, a key enzyme involved in tumor metastasis, angiogenesis and inflammation. Mini Rev. Med. Chem. 4, 693-702
14. He, X., Brenchley, P. E., Jayson, G. C., Hampson, L., Davies, J., and Hampson, I. N. (2004) Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies. Cancer Res. 64, 3928-3933
15. Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M. E., and Power, D. A. (2005) Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. Nephrology (Carlton) 10, 167-173
16. Myler, H. A., Lipke, E. A., Rice, E. E., and West, J. L. (2006) Novel heparanase-inhibiting antibody reduces neointima formation. J. Biochem. (Tokyo) 139, 339-345
17. Shafat, I., Zcharia, E., Nisman, B., Nadir, Y., Nakhoul, F., Vlodavsky, I., and Ilan, N. (2006) An ELISA method for the detection and quantification of human heparanase. Biochem. Biophys. Res. Commun. 341, 958-963
18. Levy-Adam, F., Abboud-Jarrous, G., Guerrini, M., Beccati, D., Vlodavsky, I., and Ilan, N. (2005) Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase. J. Biol. Chem. 280, 20457-20466
19. Levy-Adam, F., Miao, H. Q., Heinrikson, R. L., Vlodavsky, I., and Ilan, N. (2003) Heterodimer formation is essential for heparanase enzymatic activity. Biochem. Biophys. Res. Commun. 308, 885-891
20. Vlodavsky, I. (1999) Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. In Protocols in Cell Biology (J. S. Bonifacino, Hartford, J. B., Lippincott-Schwartz, J., and Yamada, K. M., eds) Vol. 1, pp. 10.14.11-10.14.14, John Wiley & Sons, New York
21. Gingis-Velitski, S., Zetser, A., Kaplan, V., Ben-Zaken, O., Cohen, E., Levy-Adam, F., Bashenko, Y., Flugelman, M. Y., Vlodavsky, I., and Ilan, N. (2004) Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J. Biol. Chem. 279, 44084-44092
22. Zetser, A., Bashenko, Y., Edovitsky, E., Levy-Adam, F., Vlodavsky, I., and Ilan, N. (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 66, 1455-1463
23. Zetser, A., Bashenko, Y., Miao, H.-Q., Vlodavsky, I., and Ilan, N. (2003) Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 63, 7733-7741
24. Zetser, A., Levy-Adam, F., Kaplan, V., Gingis-Velitski, S., Bashenko, Y., Schubert, S., Flugelman, M. Y., Vlodavsky, I., and Ilan, N. (2004) Processing and activation of latent heparanase occurs in lysosomes. J. Cell Sci. 117, 2249-2258
25. Liang, C. C., Park, A. Y., and Guan, J. L. (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protoc. 2, 329-333
26. Zcharia, E., Zilka, R., Yaar, A., Yacoby-Zeevi, O., Zetser, A., Metzger, S., Sarid, R., Naggi, A., Casu, B., Ilan, N., Vlodavsky, I., and Abramovitch, R. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 19, 211-221
27. Albini, A., and Benelli, R. (2007) The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nature Protoc. 2, 504-511
28. Gingis-Velitski, S., Zetser, A., Flugelman, M. Y., Vlodavsky, I., and Ilan, N. (2004) Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J. Biol. Chem. 279, 23536-23541
29. Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., and Vlodavsky, I. (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J. 15, 1661-1663
30. Freeman, C., and Parish, C. R. (1998) Human platelet heparanase: purification, characterization and catalytic activity. Biochem. J. 330, 1341-1350
31. Bernard, D., Mehul, B., Delattre, C., Simonetti, L., Thomas-Collignon, A., and Schmidt, R. (2001) Purification and characterization of the endoglycosidase heparanase 1 from human plantar stratum corneum: a key enzyme in epidermal physiology? J. Invest. Dermatol. 117, 1266-1273
32. Sanderson, R. D., Yang, Y., Kelly, T., Macleod, V., Dai, Y., and Theus, A. (2005) Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J. Cell Biochem. 96, 897-905
33. Sanderson, R. D., Yang, Y., Suva, L. J., and Kelly, T. (2004) Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 23, 341-352
34. Kram, V., Zcharia, E., Yacoby-Zeevi, O., Metzger, S., Chajek-Shaul, T., Gabet, Y., Muller, R., Vlodavsky, I., and Bab, I. (2006) Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J. Cell Physiol. 207, 784-792
35. Zcharia, E., Metzger, S., Chajek-ShaulL, T., Aingorn, H., Elikn, M., Friedmann, Y., Weinstein, T., Jin-Ping, L., Lindahl, U., and Vlodavsky, I. (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J. 18, 252-263
36. Goldshmidt, O., Yeikilis, R., Mawasi, N., Paizi, M., Gan, N., Ilan, N., Pappo, O., Vlodavsky, I., and Spira, G. (2004) Heparanase expression during normal liver development and following partial hepatectomy. J. Pathol. 203, 594-602
37. Saijo, M., Kitazawa, R., Nakajima, M., Kurosaka, M., Maeda, S., and Kitazawa, S. (2003) Heparanase mRNA expression during fracture repair in mice. Histochem. Cell Biol. 120, 493-503
38. Oliveira, S., van Bergen en Henegouwen, P. M., Storm, G., and Schiffelers, R. M. (2006) Molecular biology of epidermal growth factor receptor inhibition for cancer therapy. Expert Opin. Biol. Ther. 6, 605-617
39. Sandler, A., and Herbst, R. (2006) Combining targeted agents: blocking the epidermal growth factor and vascular endothelial growth factor pathways. Clin. Cancer Res. 12, 4421s-4425s
40. Hulett, M. D., Hornby, J. R., Ohms, S. J., Zuegg, J., Freeman, C., Gready, J. E., and Parish, C. R. (2000) Identification of activesite residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 39, 15659-15667
41. Goldshmidt, O., Zcharia, E., Cohen, M., Aingorn, H., Cohen, I., Nadav, L., Katz, B. -Z., Geiger, B., and Vlodavsky, I. (2003) Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J. 17, 1015-1025
42. Nadir, Y., Brenner, B., Zetser, A., Ilan, N., Shafat, I., Zcharia, E., Goldshmidt, O., and Vlodavsky, I. (2006) Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J. Thromb. Haemost. 4, 2443-2451